Novel Molecular Subtypes and Related Score Based on Histone Acetylation Modification in Renal Clear Cell Carcinoma.

Wang, Shichao; Xiang, Ting; Yu, Ling; Wen, Junmao; Liu, Fang; Yang, Dong; Wu, Wei; Hu, Ling

Wang, Shichao; Xiang, Ting; Yu, Ling; Wen, Junmao; Liu, Fang; Yang, Dong; Wu, Wei; Hu, Ling.

Afiliação

Wang S; Department of Cardiology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Xiang T; Guangzhou University of Chinese Medicine, Guangzhou, China.
Yu L; Guangzhou University of Chinese Medicine, Guangzhou, China.
Wen J; Department of Traditional Chinese Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Liu F; Department of Traditional Chinese Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Yang D; Guangzhou University of Chinese Medicine, Guangzhou, China.
Wu W; Guangzhou University of Chinese Medicine, Guangzhou, China.
Hu L; Department of Traditional Chinese Medicine, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.

Front Cell Dev Biol ; 9: 668810, 2021.

Article em En | MEDLINE | ID: mdl-34631694

Palavras-chave

histone (de)acetylation; immunotherapy; molecular subtype; renal clear cell carcinoma; score

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Cell Dev Biol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google